10.1111/bjd.15550 142
While we believe our product candidates, platform, knowledge, experience and scientific personnel provide us with several key competitive advantages, we face competition from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions, among others
& Ozcakar, L
This article was featured in One Great Story, New York s reading recommendation newsletter
Perioperative hyperglycemia is itself associated with adverse outcomes, so medication interruption should not be treated as trivial
NDDS can enhance in vivo pharmacokinetic behavior, increase drug stability and solubility, enable targeted drug delivery, control drug release, and possess increased prospects for clinical translation 4